| Year |
Citation |
Score |
| 2020 |
Luzi F, Gee AD, Bongarzone S. Rapid one-pot radiosynthesis of [carbonyl-C]formamides from primary amines and [C]CO. Ejnmmi Radiopharmacy and Chemistry. 5: 20. PMID 32870409 DOI: 10.1186/S41181-020-00103-Y |
0.382 |
|
| 2020 |
Bongarzone S, Raucci N, Fontana IC, Luzi F, Gee AD. Carbon-11 carboxylation of trialkoxysilane and trimethylsilane derivatives using [C]CO. Chemical Communications (Cambridge, England). PMID 32211652 DOI: 10.1039/D0Cc00449A |
0.301 |
|
| 2020 |
Luzi F, Savickas V, Taddei C, Hader S, Singh N, Gee AD, Bongarzone S. Radiolabeling of [C]FPS-ZM1, a receptor for advanced glycation end products-targeting positron emission tomography radiotracer, using a [C]CO-to-[C]CO chemical conversion. Future Medicinal Chemistry. PMID 32100545 DOI: 10.4155/Fmc-2019-0329 |
0.318 |
|
| 2018 |
Bongarzone S, Gee AD. BACE1: Now We Can See You. Journal of Medicinal Chemistry. 61: 3293-3295. PMID 29617136 DOI: 10.1021/Acs.Jmedchem.8B00474 |
0.31 |
|
| 2015 |
Bolognesi ML, Bongarzone S, Aulic S, Ai Tran HN, Prati F, Carloni P, Legname G. Rational approach to an antiprion compound with a multiple mechanism of action. Future Medicinal Chemistry. 7: 2113-20. PMID 26511069 DOI: 10.4155/Fmc.15.79 |
0.557 |
|
| 2015 |
Veronese M, Bodini B, García-Lorenzo D, Battaglini M, Bongarzone S, Comtat C, Bottlaender M, Stankoff B, Turkheimer FE. Quantification of [(11)C]PIB PET for imaging myelin in the human brain: a test-retest reproducibility study in high-resolution research tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 35: 1771-82. PMID 26058700 DOI: 10.1038/Jcbfm.2015.120 |
0.308 |
|
| 2015 |
Dheere AKH, Bongarzone S, Taddei C, Yan R, Gee AD. Synthesis of 11C-Labelled Symmetrical Ureas via the Rapid Incorporation of [11C]CO2 into Aliphatic and Aromatic Amines Synlett. DOI: 10.1055/S-0034-1381055 |
0.308 |
|
| 2014 |
Bongarzone S, Staderini M, Bolognesi ML. Multitarget ligands and theranostics: sharpening the medicinal chemistry sword against prion diseases. Future Medicinal Chemistry. 6: 1017-29. PMID 25068985 DOI: 10.4155/Fmc.14.56 |
0.56 |
|
| 2013 |
Rossetti G, Bongarzone S, Carloni P. Computational studies on the prion protein. Current Topics in Medicinal Chemistry. 13: 2419-31. PMID 24059339 DOI: 10.2174/15680266113136660170 |
0.381 |
|
| 2011 |
Bongarzone S, Bolognesi ML. The concept of privileged structures in rational drug design: focus on acridine and quinoline scaffolds in neurodegenerative and protozoan diseases. Expert Opinion On Drug Discovery. 6: 251-68. PMID 22647203 DOI: 10.1517/17460441.2011.550914 |
0.545 |
|
| 2011 |
Bongarzone S, Tran HNA, Cavalli A, Roberti M, Rosini M, Carloni P, Legname G, Bolognesi ML. Hybrid Lipoic Acid Derivatives to Attack Prion Disease on Multiple Fronts Chemmedchem. 6: 601-605. PMID 21412985 DOI: 10.1002/Cmdc.201100072 |
0.523 |
|
| 2011 |
Biarnés X, Bongarzone S, Vargiu AV, Carloni P, Ruggerone P. Molecular motions in drug design: the coming age of the metadynamics method. Journal of Computer-Aided Molecular Design. 25: 395-402. PMID 21327922 DOI: 10.1007/S10822-011-9415-3 |
0.326 |
|
| 2010 |
Bongarzone S, Tran HNA, Cavalli A, Roberti M, Carloni P, Legname G, Bolognesi ML. Parallel synthesis, evaluation, and preliminary structure-activity relationship of 2,5-diamino-1,4-benzoquinones as a novel class of bivalent anti-prion compound Journal of Medicinal Chemistry. 53: 8197-8201. PMID 21047125 DOI: 10.1021/Jm100882T |
0.578 |
|
| 2010 |
Bolognesi ML, Ai Tran HN, Staderini M, Monaco A, López-Cobeñas A, Bongarzone S, Biarnés X, López-Alvarado P, Cabezas N, Caramelli M, Carloni P, Menéndez JC, Legname G. Discovery of a class of diketopiperazines as antiprion compounds. Chemmedchem. 5: 1324-34. PMID 20540064 DOI: 10.1002/Cmdc.201000133 |
0.608 |
|
| 2010 |
Tran HN, Bongarzone S, Carloni P, Legname G, Bolognesi ML. Synthesis and evaluation of a library of 2,5-bisdiamino-benzoquinone derivatives as probes to modulate protein-protein interactions in prions. Bioorganic & Medicinal Chemistry Letters. 20: 1866-8. PMID 20172720 DOI: 10.1016/J.Bmcl.2010.01.149 |
0.521 |
|
| 2010 |
Cavalli A, Lizzi F, Bongarzone S, Belluti F, Piazzi L, Bolognesi ML. Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidates. Fems Immunology and Medical Microbiology. 58: 51-60. PMID 19845762 DOI: 10.1111/J.1574-695X.2009.00615.X |
0.573 |
|
| 2010 |
Bolognesi ML, Tran HNA, Staderini M, Monaco A, López‐Cobeñas A, Bongarzone S, Biarnés X, López‐Alvarado P, Cabezas N, Caramelli M, Carloni P, Menéndez JC, Legname G. Corrigendum: Cover Picture: Discovery of a Class of Diketopiperazines as Antiprion Compounds (ChemMedChem 8/2010) Chemmedchem. 5: 1414-1414. DOI: 10.1002/Cmdc.201090039 |
0.554 |
|
| 2010 |
Bolognesi ML, Ai Tran HN, Staderini M, Monaco A, López-Cobeñas A, Bongarzone S, Biarnés X, López-Alvarado P, Cabezas N, Caramelli M, Carloni P, Menéndez J, Legname G. Cover Picture: Discovery of a Class of Diketopiperazines as Antiprion Compounds (ChemMedChem 8/2010) Chemmedchem. 5: 1157-1157. DOI: 10.1002/Cmdc.201090031 |
0.554 |
|
| 2009 |
Kranjc A, Bongarzone S, Rossetti G, Biarnés X, Cavalli A, Bolognesi ML, Roberti M, Legname G, Carloni P. Docking Ligands on Protein Surfaces: The Case Study of Prion Protein. Journal of Chemical Theory and Computation. 5: 2565-73. PMID 26616631 DOI: 10.1021/Ct900257T |
0.521 |
|
| 2009 |
Cavalli A, Lizzi F, Bongarzone S, Brun R, Luise Krauth-Siegel R, Bolognesi ML. Privileged structure-guided synthesis of quinazoline derivatives as inhibitors of trypanothione reductase. Bioorganic & Medicinal Chemistry Letters. 19: 3031-5. PMID 19414258 DOI: 10.1016/J.Bmcl.2009.04.060 |
0.555 |
|
| Show low-probability matches. |